Hornsby Todd 4/A
4/A · Apyx Medical Corp · Filed Jun 29, 2023
Insider Transaction Report
Form 4/AAmended
Hornsby Todd
Executive Vice President
Transactions
- Sale
Common Stock
2023-06-26$7.56/sh−15,000$113,400→ 0 total - Exercise/Conversion
Common Stock
2023-06-26$1.77/sh+15,000$26,550→ 15,000 total - Exercise/Conversion
Stock Option (Option to Buy)
2023-06-26−15,000→ 20,000 totalExercise: $1.77From: 2019-12-18Exp: 2025-12-17→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]The reported sale occurred automatically pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on March 21, 2023
- [F2]This transaction was executed in multiple trades at prices ranging from $7.30 to $7.70. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]The original Form 4 is hereby amended to correct the amount of securities beneficially owned by the Reporting Person (as set forth in Column 5 of Table I) following the previously reported transactions